Rilutek (KAISER FOUNDATION HOSPITALS)
Welcome to the PulseAid listing for the Rilutek drug offered from KAISER FOUNDATION HOSPITALS. This Benzothiazole [EPC],Benzothiazoles [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | KAISER FOUNDATION HOSPITALS |
| NON-PROPRIETARY NAME: | riluzole |
| SUBSTANCE NAME: | RILUZOLE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Benzothiazole [EPC],Benzothiazoles [Chemical/Ingredient] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2014-01-20 |
| END MARKETING DATE: | 0000-00-00 |
Rilutek HUMAN PRESCRIPTION DRUG Details:
| Item Description | Rilutek from KAISER FOUNDATION HOSPITALS |
| LABELER NAME: | KAISER FOUNDATION HOSPITALS |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 50(mg/1) |
| START MARKETING DATE: | 2014-01-20 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0179-0143_48c67779-1716-4aa6-bcde-1e5803f74503 |
| PRODUCT NDC: | 0179-0143 |
| APPLICATION NUMBER: | NDA020599 |
Other RILUZOLE Pharmaceutical Manufacturers / Labelers:
